The present disclosure describes a method of treating p53-deficient cells using a niclosamide derivative according to formula (I). The present disclosure further describes a method of treating cancer using the compound according to formula I, as well as methods of screening to identify a compound that selectively target cells wherein p53 is deficient or non-functional.